Skip to content

Alamar Biosciences ALMR Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

CoreWeave, Inc.
 logo
CoreWeave, Inc. CRWV
$167M+149%
MicroStrategy logo
MicroStrategyMSTR
$1.53M-31.8%
TE Connectivity logo
TE ConnectivityTEL
$39M+11.4%
W.W. Grainger logo
W.W. GraingerGWW
$20M0.0%
PepsiCo logo
PepsiCoPEP
$162M+11.7%
CRH logo
CRHCRH
$83M+40.7%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's operating lease right-of-use asset amortization?
Alamar Biosciences (ALMR) reported operating lease right-of-use asset amortization of $461K in Q1 2026.